A. Gulbrandsen

Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients

O. Andreassen, V. Steen, R. McCreadie, 1997, Psychopharmacology.

Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology.

O. Andreassen, V. Steen, J. Idle, 1995, Pharmacogenetics.

Structures and magnetic properties of Co(II)Cu(II) and Ni(II)Cu(II) compounds incorporating the obp=oxamidobis(N,N′-propionato) ligand

O. Kahn, K. Nakatani, A. Gulbrandsen, 1993 .

A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients

A. Molven, V. Steen, R. Løvlie, 2000, Molecular Psychiatry.

Homologous unequal cross-over involving a 2.8 kb direct repeat as a mechanism for the generation of allelic variants of human cytochrome P450 CYP2D6 gene.

A. Molven, V. Steen, N. Aarskog, 1995, Human molecular genetics.

The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness.

Y. Osher, R. Belmaker, V. Steen, 1998, Pharmacogenetics.

Lack of genetic variation in the coding region of the myo-inositol monophosphatase gene in lithium-treated patients with manic depressive illness.

V. Steen, H. Eiken, A. Gulbrandsen, 1996, Pharmacogenetics.